Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 04, 2013
AAIPharma Services, Corp. (“AAI”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API development and...
read more
AAIPharma Services Corporation (AAI)/Cambridge Major Laboratories, Inc. (CML), a provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, has announced its new brand and identity as a leading ...
read more
Thursday, February 06, 2014
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc (“CML”), a global leader in pharmaceutical API development ...
read more
Tuesday, December 11, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company’s senior director of biopharmaceutical development for its ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company’s senior director of parenteral operations for its manufacturing facility in ...
read more
Wednesday, December 12, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
read more
Tuesday, December 22, 2015
AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced additional capabilities and capacity for oral solid ...
read more
AAD, developer of rapid diagnostic and data systems, today announced that it has been awarded a federal contract for the development of an innovative system for the earlier detection of severe infection, including sepsis. The easy-to-use system is ...
read more
Monday, November 30, 2020
A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business.
read more
908 Devices announced a joint innovation partnership with Hangzhou Just Biotherapeutics.
read more
The 6000TOCi on-line TOC sensor delivers reliable data to demonstrate compliance in Pharmaceutical water systems.
read more
Wednesday, December 01, 2021
AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a new partnership with 4TEEN4 Pharmaceuticals GmbH to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody ...
read more
Tuesday, October 22, 2019
4G Clinical announced its recognition as the BSMA Supply Chain Management Excellence and Innovation Award 2019 recipient for its utilization of NLP to turn study parameters into detailed forecasts.
read more
4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, entered an agreement to receive a growth equity investment of over $230M from Goldman Sachs. The investment will be used to fund 4G Clinical's continued global ...
read more